Edgewise Therapeutics, Inc.

EWTX·NASDAQ·$33.56Share Price as of 11/2·$4BMarket Cap as of 11/2

Financials

10-QQ2 ended 06/30/2608/06/26 10-QQ1 ended 03/31/2605/07/26 10-KFY 202502/26/26 10-QQ3 ended 09/30/2511/06/25 10-QQ2 ended 06/30/2508/07/25

Disclosures

8-KCurrent report08/06/26 8-K/ACurrent report (amended)07/16/26 8-KCurrent report07/13/26 8-KCurrent report06/05/26 8-KCurrent report06/01/26

Prospectuses and Registrations

S-8Registration of securities for employees05/07/26 424B5Prospectus supplement04/02/25 S-8Registration of securities for employees03/03/25 S-8Registration of securities for employees11/07/24 S-3ASRAutomatic shelf registration05/10/24

Proxies

DEF 14ADefinitive proxy04/23/26 DEFA14AAdditional proxy materials04/23/26 DEFA14AAdditional proxy materials05/14/25 DEF 14ADefinitive proxy04/29/25 DEFA14AAdditional proxy materials04/29/25

Ownership

Form 4Insider transaction10/02/26 4/AInsider transaction (amended)08/17/26 4/AInsider transaction (amended)08/17/26 4/AInsider transaction (amended)08/17/26 4/AInsider transaction (amended)08/17/26

Other

ARSAnnual report to shareholders04/23/26 ARSAnnual report to shareholders04/28/23 EFFECTRequest for effectiveness05/05/22 CORRESPCorrespondence with the SEC05/03/22 UPLOADLetter from the SEC04/08/22